Format
Sort by
Items per page

Send to

Choose Destination

Search results

Items: 13

1.

Hypoxia and acidosis: immune suppressors and therapeutic targets.

Damgaci S, Ibrahim-Hashim A, Enriquez-Navas PM, Pilon-Thomas S, Guvenis A, Gillies RJ.

Immunology. 2018 Jul;154(3):354-362. doi: 10.1111/imm.12917. Epub 2018 Mar 30. Review.

PMID:
29485185
2.

Spatial Heterogeneity and Evolutionary Dynamics Modulate Time to Recurrence in Continuous and Adaptive Cancer Therapies.

Gallaher JA, Enriquez-Navas PM, Luddy KA, Gatenby RA, Anderson ARA.

Cancer Res. 2018 Apr 15;78(8):2127-2139. doi: 10.1158/0008-5472.CAN-17-2649. Epub 2018 Jan 30.

PMID:
29382708
3.

Tris-base buffer: a promising new inhibitor for cancer progression and metastasis.

Ibrahim-Hashim A, Abrahams D, Enriquez-Navas PM, Luddy K, Gatenby RA, Gillies RJ.

Cancer Med. 2017 Jul;6(7):1720-1729. doi: 10.1002/cam4.1032. Epub 2017 May 29.

4.

Defining Cancer Subpopulations by Adaptive Strategies Rather Than Molecular Properties Provides Novel Insights into Intratumoral Evolution.

Ibrahim-Hashim A, Robertson-Tessi M, Enriquez-Navas PM, Damaghi M, Balagurunathan Y, Wojtkowiak JW, Russell S, Yoonseok K, Lloyd MC, Bui MM, Brown JS, Anderson ARA, Gillies RJ, Gatenby RA.

Cancer Res. 2017 May 1;77(9):2242-2254. doi: 10.1158/0008-5472.CAN-16-2844. Epub 2017 Mar 1.

5.

Exploiting evolutionary principles to prolong tumor control in preclinical models of breast cancer.

Enriquez-Navas PM, Kam Y, Das T, Hassan S, Silva A, Foroutan P, Ruiz E, Martinez G, Minton S, Gillies RJ, Gatenby RA.

Sci Transl Med. 2016 Feb 24;8(327):327ra24. doi: 10.1126/scitranslmed.aad7842.

6.

Application of Evolutionary Principles to Cancer Therapy.

Enriquez-Navas PM, Wojtkowiak JW, Gatenby RA.

Cancer Res. 2015 Nov 15;75(22):4675-80. doi: 10.1158/0008-5472.CAN-15-1337. Epub 2015 Nov 2. Review.

7.

Structures of glycans bound to receptors from saturation transfer difference (STD) NMR spectroscopy: quantitative analysis by using CORCEMA-ST.

Enríquez-Navas PM, Guzzi C, Muñoz-García JC, Nieto PM, Angulo J.

Methods Mol Biol. 2015;1273:475-87. doi: 10.1007/978-1-4939-2343-4_28.

PMID:
25753726
8.

Assembling different antennas of the gp120 high mannose-type glycans on gold nanoparticles provides superior binding to the anti-HIV antibody 2G12 than the individual antennas.

Chiodo F, Enríquez-Navas PM, Angulo J, Marradi M, Penadés S.

Carbohydr Res. 2015 Mar 20;405:102-9. doi: 10.1016/j.carres.2014.07.012. Epub 2014 Jul 30.

PMID:
25573666
9.

STD NMR study of the interactions between antibody 2G12 and synthetic oligomannosides that mimic selected branches of gp120 glycans.

Enríquez-Navas PM, Chiodo F, Marradi M, Angulo J, Penadés S.

Chembiochem. 2012 Jun 18;13(9):1357-65. doi: 10.1002/cbic.201200119. Epub 2012 May 24.

PMID:
22628288
10.

Gold nanoparticles coated with oligomannosides of HIV-1 glycoprotein gp120 mimic the carbohydrate epitope of antibody 2G12.

Marradi M, Di Gianvincenzo P, Enríquez-Navas PM, Martínez-Ávila OM, Chiodo F, Yuste E, Angulo J, Penadés S.

J Mol Biol. 2011 Jul 29;410(5):798-810. doi: 10.1016/j.jmb.2011.03.042. Epub 2011 Mar 25.

PMID:
21440555
11.

A solution NMR study of the interactions of oligomannosides and the anti-HIV-1 2G12 antibody reveals distinct binding modes for branched ligands.

Enríquez-Navas PM, Marradi M, Padro D, Angulo J, Penadés S.

Chemistry. 2011 Feb 1;17(5):1547-60. doi: 10.1002/chem.201002519. Epub 2011 Jan 5.

PMID:
21268157
12.

Ligand-receptor binding affinities from saturation transfer difference (STD) NMR spectroscopy: the binding isotherm of STD initial growth rates.

Angulo J, Enríquez-Navas PM, Nieto PM.

Chemistry. 2010 Jul 12;16(26):7803-12. doi: 10.1002/chem.200903528.

PMID:
20496354
13.

Carbohydrate-carbohydrate interaction prominence in 3D supramolecular self-assembly.

Fuss M, Luna M, Alcántara D, de la Fuente JM, Enríquez-Navas PM, Angulo J, Penadés S, Briones F.

J Phys Chem B. 2008 Sep 18;112(37):11595-600. doi: 10.1021/jp804191j. Epub 2008 Aug 26.

PMID:
18729395

Supplemental Content

Loading ...
Support Center